Mesecar Apr 2026

), helping guide the development of treatments like .

He is the Robert Wallace Miller Director of the Purdue Institute for Cancer Research , where he leads efforts in developing novel cancer therapies, diagnostics, and targeting cancer at the cellular level. mesecar

His work includes developing non-covalent, selective inhibitors designed to work against multiple emerging coronavirus strains, including MERS-CoV. ), helping guide the development of treatments like

He specializes in determining high-resolution 3D structures of enzymes (such as 3CLpro and PLpro) in coronaviruses and cancer to design selective drugs. mesecar

He is involved in translational research to turn basic molecular findings into commercial drugs for cancer and Alzheimer's disease.